¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"variable orifice meter"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • variable region
    °¡º¯ºÎÀ§
  • blood flow meter
    Ç÷·ù°è
  • CO2 meter
    ÀÌ»êȭź¼ÒÃøÁ¤±â
  • dose rate meter
    ¼±·®·ü°è, ¼±·®·üÃøÁ¤±â
  • fixed pressure difference meter
    °íÁ¤¾Ð·ÂÂ÷°è
  • gas flow meter
    ±âüÀ¯·®°è
  • gas meter
    ±âü·®°è, °¡½º¹ÌÅÍ
  • heart rate meter
    ½É¹Ú°è, ½ÉÀå¹Úµ¿°è
  • heating volt meter
    °¡¿­Àü¾Ð°è
  • hardness meter
    °æµµ°è
  • meter
    °è, ÃøÁ¤±â, ¹ÌÅÍ
  • meter candle
    ¹ÌÅÍÃ˱¤
  • potential acuity meter
    ÀáÀç½Ã·ÂÃøÁ¤±â
  • peak flow meter
    ÃÖ´ëÀ¯·®°è, ÃÖ°íÀ¯·®°è
  • personal meter
    Àοø°è±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • distorter variable
    ±³¶õº¯¼ö
  • independent variable
    µ¶¸³º¯¼ö
  • intermediate variable
    Áß°£º¯¼ö
  • intervening variable
    Á¶Á¤º¯¼ö, °£¼·º¯¼ö
  • manifestational variable
    Á¾¼Óº¯¼ö
  • moderator variable
    Á¶Á¾º¯¼ö
  • passenger variable
    µ¿¹Ýº¯¼ö
  • variable region
    °¡º¯ºÎÀ§
  • variable strabismus
    °¡º¯»ç½Ã
  • variable bandwidth technique
    ´Ùº¯Á֯ļöÆø±â¹ý
  • variable
    º¯¼ö, °¡º¯
  • blood flow meter
    Ç÷·ù°è
  • CO2 meter
    ÀÌ»êȭź¼ÒÃøÁ¤±â
  • meter candle
    ¹ÌÅÍÃ˱¤
  • dose rate meter
    ¼±·®À²°è, ¼±·®·üÃøÁ¤±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • variable numbers
    º¯¼ö(ËÒËà).
  • variable of integration
    ÀûºÐº¯¼ö.
  • variable region
    °¡º¯ºÎÀ§(ʦܨݻêÈ).
  • variable repeat of tandem repeats
    ¹Ýº¹À¯ÀüÀÚÀÇ ÀÓÀǹݺ¹(ìòëòÚãÜÖ)
  • variable strabismus
    °¡º¯»ç½Ã
  • variable(s)
    º¯¼ö(ܨâ¦), º¯ÀÎ(ܨì×).
  • blood flow meter
    Ç÷·ù°è(úì׵ͪ).
  • dose rate meter
    ¼±·®À²°è, -ÃøÁ¤±â
  • exposure meter
    ³ëÃâ°è(ËȨ̀˭).
  • fixed pressure difference meter
    °íÁ¤¾Ð·ÂÂ÷°è.
  • flow meter
    À¯·®(êüÕá)<À¯¼Ó(êüáÜ)>°è(Ìþ).
  • flow meter
    À¯·®<À¯¼Ó>°è.
  • flow meter controlled vaporizer
    À¯·®Á¶Àý±âÈ­±â.
  • gas flow meter
    ±âüÀ¯¼Ó°è(¡­êüáÜͪ).
  • gas meter
    ±âü·®°è(Ѩô÷åÖͪ), °¡½º¹ÌÅÍ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Orifice of pulmonary trunk
    ÇãÆÄµ¿¸Æ±¸¸Û
    [¿¾ ¿ë¾î] Æóµ¿¸Æ±¸
  • Pyloric orifice
    ³¯¹®±¸¸Û
    [¿¾ ¿ë¾î] À¯¹®±¸
  • Uterine orifice
    Àڱñ¸¸Û
    [¿¾ ¿ë¾î] Àڱñ¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Ao orifice area
AVO aortic valve opening; aortic valve orifice; atrioventricular opening
CAVO common atrioventricular orifice
EOA effective orifice area; erosive osteoarthritis; esophageal obturator airway; examination, opinion, a...
LUO left ureteral orifice
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CVID Common Variable Immuno-Deficiency
CVH Common variable hypogammaglobulinemia
CVI Common variable immunodeficiency
HVR Hyper-Variable Region
scFv Single chain variable fragments
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pharyngeal orifice of eustachian tube
    À¯½ºÅ¸Å°¿À°ü Àεα¸
  • root canal orifice
    ±Ù°ü±¸
    Ä¡¼ö°­ÀÇ ÀúºÎ¿¡ ÀÖ´Â °³±¸·Î¼­ ±Ù°ü°ú ÅëÇÑ´Ù.
  • flow meter
    À¯·®°è, À¯¼Ó°è
    ¾×ü ¶Ç´Â ±âüÀÇ À¯¼ÓÀ» ÃøÁ¤ÇÏ´Â ±â±¸.
  • heart rate meter
    ½É¹Ú°è, ½ÉÀå ¹Úµ¿°è, ½É¹Úµ¿°è
  • mA meter
    Àü·ù°è
  • meter
    ¹ÌÅÍ
    1. ¹ÌÅ͹ý ±æÀÌ ÃøÁ¤ÀÇ ±âº» ´ÜÀ§·Î¼­ ¾à 39.37ÀÎÄ¡¿¡ ÇØ´çµÈ´Ù. °ú°Å¿¡´Â ¹ÌÅÍ ¿ø±â·Î¼­ ¹é±Ý°ú iridium ÇÕ±ÝÀ¸·Î ¸¸µç ºÀÀÇ ±æÀ̰¡ »ç¿ëµÇ¾ú´Âµ¥ À̰ÍÀº ÆÄ¸® ±Ù±³ÀÇ ±¹Á¦µµ·®Çü »ç¹«±¹
  • nitrogen meter
    Áú¼Ò°è
  • pH meter
    pH ¹ÌÅÍ, »êµµ ÃøÁ¤±â
  • serum protein meter
    Ç÷û ´Ü¹é°è
    Ç÷û ´Ü¹é Á¤·®¿ëÀÇ ¼ÒÇü ±¼Àý°è.
  • strain meter
    ÀǷ°è
  • volt meter
    Àü¾Ð°è
  • watt hour meter
    ¿ÍÆ®-½Ã¸ÞŸ, Àü·Â°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
variable antigen <immunology> Term usually applied to the surface antigens of those parasitic or pathogenic organisms that can alter their antigenic character to evade host immune responses. (See antigenic variation).
(18 Nov 1997)
variable deceleration Transient foetal bradycardia usually denoting compression of the umbilical cord which may occur at any time in relation to a uterine contraction.
(05 Mar 2000)
variable gene <molecular biology> Those regions in the amino acid sequence of both the heavy and the light chains of immunoglobulins where there is considerable sequence variability from one immunoglobulin to other of the same class, in contrast to constant sequence (C) regions. The V regions are associated with the antigen binding areas. They contain hypervariable regions of particularly high sequence diversity.
(18 Nov 1997)
variable region <molecular biology> Those regions in the amino acid sequence of both the heavy and the light chains of immunoglobulins where there is considerable sequence variability from one immunoglobulin to other of the same class, in contrast to constant sequence (C) regions. The V regions are associated with the antigen binding areas. They contain hypervariable regions of particularly high sequence diversity.
(18 Nov 1997)
variable surface glycoprotein <protein> One of a battery of antigenicdeterminants expressed by a microorganism to elude immune detection.
(09 Oct 1997)
random variable A variable that may assume a set of values, each with fixed probabilities or probability densities (its distribution), in such a way that the total probability assigned to the distribution is unity; the random variable may be discrete, continuous, or mixed discrete-continuous.
(05 Mar 2000)
mixed discrete-continuous random variable <statistics> A random variable that may assume some values with probabilities and others with probability densities.
For example, in a 35-year-old man with familial polyposis of the colon, the distribution of time until malignant disease occurs consists of a probability that he already has cancer (which would be assigned the waiting time 0), a probability density of developing it in the future and a probability that he will die of some other cause before he develops cancer.
(05 Mar 2000)
moderator variable A variable that interacts by virtue of being antecedent or intermediate in the causal pathway.
(05 Mar 2000)
common variable immunodeficiency Heterogeneous group of immunodeficiency syndromes characterised by hypogammaglobulinaemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.
(12 Dec 1998)
condenser, variable-focus <microscopy> Essentially an Abbe condenser in which the upper lens element is fixed and the lower movable. The lower lens may be used to focus the illumination between the elements so that it emerges from the stationary lens as a large diameter parallel bundle. The field of low-power objectives may thus be filled without removing the top element. at the opposite extreme it can be adjusted to have a numerical aperture as high as 1.3.
See: illumination, critical.
(05 Aug 1998)
continuous random variable Continuous variable that may randomly assume any value in its domain but any particular value has no probability of occurring, only a probability density.
(05 Mar 2000)
continuous variable A variable that may take on any value in an interval or intervals (its domain).
(05 Mar 2000)
dependent variable In experiments, a variable that is influenced by or dependent upon changes in the independent variable; e.g., the amount of a written passage retained (dependent variable) as a function of the different numbers of minutes (independent variable) allowed to study the passage.
(05 Mar 2000)
discrete random variable A random variable that may assume a countable number of values, each with a probability strictly greater than zero.
(05 Mar 2000)
discrete variable A variable that may assume only a countable (usually finite) number of values.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • parking meter
    ÁÖÂ÷ ½Ã°£ ÀÚµ¿ Ç¥½Ã±â
  • postage meter
    ¿ìÆí ¿ä±Ý ¹ÌÅÍ(¿ìÇ¥ ´ë½Å ½ºÅÆÇÁ¸¦ ´©¸£´Â °è±â)
  • rate meter
    (°è¼ö±âÀÇ)°è¼öÀ²°è
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á